The regulator conducted a postmarketing trial which suggested increased risk of Guillain-Barré syndrome (GBS) 42 days ...
The World Health Organization (WHO) said it has not observed any unusual outbreak patterns in China as the reported number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback